Trials that use: Confidence intervals
New to this method? Read the tutorial →
5,320 results
- “Answers in Hours” A Randomized Controlled Trial Using Microbiome Metagenomics for Bile Duct Cultures: Complete Statistical AnalysisIndependent statistical analysis of "Answers in Hours" A Randomized Controlled Trial Using Microbiome Metagenomics for Bile Duct Cultures: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- “Completeness of Response” Following Treatment With Treximet™ for Migraine: Complete Statistical AnalysisIndependent statistical analysis of "Completeness of Response" Following Treatment With Treximet™ for Migraine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00893737).
- (DECIDE)Complete statistical analysis of the phase 3 DECIDE trial comparing BIIB019 (daclizumab high yield process) with interferon beta-1a in participants with relapsing-remitting multiple sclerosis, including trial design, registered endpoints, regression methods, efficacy…
- (EPOC)Independent statistical analysis of Evaluation of Point-of-Care (EPOC) for COVID-19: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05227404).
- [F-18] Fluorothymidine (FLT) Imaging on Patients With Primary Brain Tumors: Complete Statistical AnalysisIndependent statistical analysis of [F-18] Fluorothymidine (FLT) Imaging on Patients With Primary Brain Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00707343).
- 0822GCC: Phase 2 Study of Efficacy and Safety of Apricoxib/Placebo With Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of 0822GCC: Phase 2 Study of Efficacy and Safety of Apricoxib/Placebo With Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size…
- 1/2 A Multi-site Systems Intervention for Unemployed Persons With Social Anxiety: Complete Statistical AnalysisIndependent statistical analysis of 1/2 A Multi-site Systems Intervention for Unemployed Persons With Social Anxiety: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- 1% Chloroprocaine(PF) vs. Bupivacaine Spinals: Complete Statistical AnalysisIndependent statistical analysis of 1% Chloroprocaine(PF) vs. Bupivacaine Spinals: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03324984).
- 12 Month Open Extension of TNS for ADHD.: Complete Statistical AnalysisIndependent statistical analysis of 12 Month Open Extension of TNS for ADHD.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03888391).
- 12- Week Open Label Treatment of Refractory Bipolar Depression: Complete Statistical AnalysisIndependent statistical analysis of 12- Week Open Label Treatment of Refractory Bipolar Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00223496).
- 12-Month Stability of Diurnal IOP Control on Cosopt: Complete Statistical AnalysisIndependent statistical analysis of 12-Month Stability of Diurnal IOP Control on Cosopt: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00379834).
- 1303GCC: Trastuzmab & Pertuzumab With Hormonal Therapy or Chemotherapy in Women Aged 60 and Over.: Complete Statistical AnalysisIndependent statistical analysis of 1303GCC: Trastuzmab & Pertuzumab With Hormonal Therapy or Chemotherapy in Women Aged 60 and Over.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- 15 mg Mirtazapine Orally Disintegrating Tablets, Non-Fasting: Complete Statistical AnalysisIndependent statistical analysis of 15 mg Mirtazapine Orally Disintegrating Tablets, Non-Fasting: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00834197).
- 1565GCCIndependent statistical analysis of Decitabine and Talazoparib in Untreated AML and R/R AML: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02878785).
- 17-AAG in Treating Patients With Relapsed or Refractory Anaplastic Large Cell Lymphoma, Mantle Cell Lymphoma, or Hodgkin’s Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of 17-AAG in Treating Patients With Relapsed or Refractory Anaplastic Large Cell Lymphoma, Mantle Cell Lymphoma, or Hodgkin's Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- 177Lu-PSMA-617 and Pembrolizumab in Treating Patients With Metastatic Castration-Resistant Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of 177Lu-PSMA-617 and Pembrolizumab in Treating Patients With Metastatic Castration-Resistant Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- 18-week add-on to Metformin Comparison of Saxagliptin and Sitagliptin in Adult Patients With Type 2 Diabetes (T2D): Complete Statistical AnalysisIndependent statistical analysis of 18-week add-on to Metformin Comparison of Saxagliptin and Sitagliptin in Adult Patients With Type 2 Diabetes (T2D): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- 180 Degree vs. 360 Degree Selective Laser Trabeculoplasty as Initial Therapy for Glaucoma: Complete Statistical AnalysisIndependent statistical analysis of 180 Degree vs. 360 Degree Selective Laser Trabeculoplasty as Initial Therapy for Glaucoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- 18F- Fluorothymidine to Evaluate Treatment Response in Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of 18F- Fluorothymidine to Evaluate Treatment Response in Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00775268).
- 18F-AV-1451 Autopsy Study: Complete Statistical AnalysisIndependent statistical analysis of 18F-AV-1451 Autopsy Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02516046).
- 18F-fluciclovine PET in Metastatic Castration Resistant Prostate Cancer Treated With Life Prolonging Therapies: Complete Statistical AnalysisIndependent statistical analysis of 18F-fluciclovine PET in Metastatic Castration Resistant Prostate Cancer Treated With Life Prolonging Therapies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- 1974Independent statistical analysis of Effects of Single Doses of Liraglutide and Dapagliflozin on Ketogenesis in Type 1 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- 2 Dose Neuraxial Morphine for Prevention of PDPH: Complete Statistical AnalysisIndependent statistical analysis of 2 Dose Neuraxial Morphine for Prevention of PDPH: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02473276).
- 2 Doses of Ferrlecit Versus Oral Iron to Treat Iron-deficiency Anemia in Peritoneal Dialysis Patients.: Complete Statistical AnalysisIndependent statistical analysis of 2 Doses of Ferrlecit Versus Oral Iron to Treat Iron-deficiency Anemia in Peritoneal Dialysis Patients.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- 2 Phase Comparison of Pre-operative CT and PET Images for Metastatic Colorectal Cancer: Complete Statistical AnalysisIndependent statistical analysis of 2 Phase Comparison of Pre-operative CT and PET Images for Metastatic Colorectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- 2-DeoxyglucoseIndependent statistical analysis of A Phase I/II Trial of 2-Deoxyglucose (2DG) for the Treatment of Advanced Cancer and Hormone Refractory Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- 2/2 D-Cycloserine Augmentation of CBT for Pediatric OCD: Complete Statistical AnalysisIndependent statistical analysis of 2/2 D-Cycloserine Augmentation of CBT for Pediatric OCD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01404208).
- 20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study of a 4-Dose Series in Healthy Infants: Complete Statistical AnalysisIndependent statistical analysis of 20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study of a 4-Dose Series in Healthy Infants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- 2022-10Independent statistical analysis of Ambispective Study Evaluating the Clinical Results of SAGITTA EVL R Revision Stems: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- 24-hour Blood Pressure Measurements and Ischemic Conditioning: Complete Statistical AnalysisIndependent statistical analysis of 24-hour Blood Pressure Measurements and Ischemic Conditioning: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03303404).
- 24-hour IOP-lowering Effect of 0.01% Bimatoprost: Complete Statistical AnalysisIndependent statistical analysis of 24-hour IOP-lowering Effect of 0.01% Bimatoprost: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01271686).
- 24-hour IOP-lowering Effect of Brimonidine 0.1%: Complete Statistical AnalysisIndependent statistical analysis of 24-hour IOP-lowering Effect of Brimonidine 0.1%: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00457795).
- 276Independent statistical analysis of A Phase I/II Evaluation of ADXS11-001, Mitomycin, 5-fluorouracil (5-FU) and IMRT for Anal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- 28 mm Ceramic-on-Ceramic Acetabular Cup Total Hip Replacement Study: Complete Statistical AnalysisIndependent statistical analysis of 28 mm Ceramic-on-Ceramic Acetabular Cup Total Hip Replacement Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00208507).
- 2CAREIndependent statistical analysis of Coenzyme Q10 in Huntington's Disease (HD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00608881).
- 3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis: Complete Statistical AnalysisIndependent statistical analysis of 3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis: primary endpoint results, effect estimate with confidence interval,…
- 3-year, Open-Label Study Evaluating Safety, Tolerability, and Efficacy of Lorecivivint in Knee Osteoarthritis: Complete Statistical AnalysisIndependent statistical analysis of 3-year, Open-Label Study Evaluating Safety, Tolerability, and Efficacy of Lorecivivint in Knee Osteoarthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- 306A/306BIndependent statistical analysis of A Two Part Study (306A/306B) to Assess Droxidopa in Treatment of NOH in Patients With Parkinson's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- 32543Independent statistical analysis of Effect of Montelukast Therapy in Obstructive Sleep Apnea(OSA) Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01027806).
- 337Independent statistical analysis of BrUOG 337: Olaparib Prior to Radical Prostatectomy For Advanced Prostate Cancer Defects in DNA Repair Genes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- 36-month Special Drug Use Surveillance on Frequency of Bone Fractures With Sodium Risedronate 75 mg Tablets: Complete Statistical AnalysisIndependent statistical analysis of 36-month Special Drug Use Surveillance on Frequency of Bone Fractures With Sodium Risedronate 75 mg Tablets: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- 3CIndependent statistical analysis of Campath, Calcineurin Inhibitor Reduction and Chronic Allograft Nephropathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01120028).
- 3Dvs2DforUCIndependent statistical analysis of Evaluation of 3D Visualization for Total Colectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02370056).
- 3M Oral Rinse Incidence and Patient Acceptance of Sloughing When Used With Sodium Lauryl Sulfate (SLS) Toothpastes: Complete Statistical AnalysisIndependent statistical analysis of 3M Oral Rinse Incidence and Patient Acceptance of Sloughing When Used With Sodium Lauryl Sulfate (SLS) Toothpastes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- 3MVIndependent statistical analysis of Evaluation of Many Men, Many Voices, An STD/HIV Prevention Intervention for Black MSM: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- 4 Pillars Toolkit for Adolescent Vaccination: Complete Statistical AnalysisIndependent statistical analysis of 4 Pillars Toolkit for Adolescent Vaccination: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02165722).
- 4 Week Correction Study in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Undergoing Dialysis: Complete Statistical AnalysisIndependent statistical analysis of 4 Week Correction Study in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Undergoing Dialysis: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- 437_EsComIndependent statistical analysis of Community Spirit in Residence for the Elderly: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06441877).
- 5-Fluorouracil, Bevacizumab, and Radiation Followed by Modified FOLFOX6 and Bevacizumab in Stage II/III Rectal Cancer: Complete Statistical AnalysisIndependent statistical analysis of 5-Fluorouracil, Bevacizumab, and Radiation Followed by Modified FOLFOX6 and Bevacizumab in Stage II/III Rectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- 5% Lidocaine Ointment in the Treatment of Vulvar Vestibulitis: Complete Statistical AnalysisIndependent statistical analysis of 5% Lidocaine Ointment in the Treatment of Vulvar Vestibulitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00450242).